Partners Innovation Fund
David de Graaf now has his $28.5M launch round in place, building a coenzyme A platform in his latest startup
Longtime biotech exec David de Graaf has the cash he needs to set up the preclinical foundation for his coenzyme A metabolism company Comet. A …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
